Shock Wave Versus Vacuum Assisted Closure on Chronic Diabetic Foot Ulcer

Sponsor
Cairo University (Other)
Overall Status
Completed
CT.gov ID
NCT05849701
Collaborator
Kafrelsheikh University (Other)
30
1
2
13.2
2.3

Study Details

Study Description

Brief Summary

This study will be a randomized, open-label, pretest post-test with two study groups.

Condition or Disease Intervention/Treatment Phase
  • Device: Shock wave therapy
  • Device: Vacuum-assisted closure
N/A

Detailed Description

The randomization procedure will be performed by a simple drawing of lots (A or B) which determined whether participants would receive Shock wave therapy ( group A) or vacuum-assisted closure therapy (group B). Patients in both groups will receive the same medical treatment and nursing care.

Study Design

Study Type:
Interventional
Actual Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Randomized controlled trialRandomized controlled trial
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Shock Wave Versus Vacuum-assisted Closure on Chronic Diabetic Foot Ulcer
Actual Study Start Date :
Mar 10, 2022
Actual Primary Completion Date :
Feb 14, 2023
Actual Study Completion Date :
Apr 15, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Shock wave therapy group

Patients in this group were managed by shock wave therapy, using gymna Shock Master 500 with an input voltage of alternating current (AC) 220 Volte, 100 pulses at 0.13 m joule/mm at 3 Hz per session, for six weeks

Device: Shock wave therapy
using gymna Shock Master 500 with an input voltage of alternating current (AC) 220 Volte, 100 pulses at 0.13 m joule/mm at 3 Hz per session for 6 weeks.
Other Names:
  • Traditional medical and wound care
  • Active Comparator: Vacuum-assisted closure group

    the patients in this group were treated by vacuum-assisted closure using KCI's Vacuum Assisted Closure Device, the pump delivered an intermittent negative pressure of -125 mmHg. The cycle was of seven minutes during which the pump was on for five minutes and off for two minutes, The dressings were changed on the fourth day.

    Device: Vacuum-assisted closure
    Using KCI's Vacuum Assisted Closure Device for six weeks, the pump delivered an intermittent negative pressure of -125 mmHg. The cycle was of seven minutes during which the pump was on for five minutes and off for two minutes, the dressings were changed on the fourth day.
    Other Names:
  • Traditional medical and wound care
  • Outcome Measures

    Primary Outcome Measures

    1. Wound surface area [change from baseline and after six weeks of intervention.]

      using the ruler method to to measure the longest length and the widest width and multiplying them.

    2. Wound volume [change from baseline and after six weeks of intervention.]

      using the ruler method to to measure the longest length, the widest width and the deepest area multiplying them.

    Secondary Outcome Measures

    1. Wound surface area [change from baseline and after two weeks of intervention.]

      using the ruler method to to measure the longest length and the widest width and multiplying them.

    2. Wound surface area [change from baseline and after four weeks of intervention.]

      using the ruler method to to measure the longest length and the widest width and multiplying them.

    3. Wound volume [change from baseline and after two weeks of intervention.]

      using the ruler method to to measure the longest length, the widest width and the deepest area multiplying them.

    4. Wound volume [change from baseline and after four weeks of intervention.]

      using the ruler method to to measure the longest length, the widest width and the deepest area multiplying them.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    40 Years to 60 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    All patients had chronic diabetic foot ulcers that did not heal within six weeks of the incidence.

    Exclusion Criteria:

    Patients with acute cellulitis, osteomyelitis, or gangrene anywhere in the affected extremity.

    Patients with renal, hepatic, neurological, or malignant diseases.

    Patients with severe protein malnutrition (serum albumin < 2.0 g/dl) or severe anemia (Hgb < 7.0 g/dl).

    Patients with an ankle-brachial index < 0.7, absence of the dorsalis pedis or posterior tibial artery pulse.

    Patients who had debridement; pregnancy.

    Patients who refused to join the study, or to sign the written consent.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Shaimaa Mohamed Ahmed El Sayeh Cairo Egypt 02

    Sponsors and Collaborators

    • Cairo University
    • Kafrelsheikh University

    Investigators

    • Principal Investigator: Shaimaa MA El Sayeh, PhD, Lecturer at Faculty of Physical Therapy, Cairo University
    • Principal Investigator: Nesrein A Abdel Rashed, PhD, Assistant Professor at Faculty of Physical Therapy, Cairo University
    • Principal Investigator: Hamada A Hamada, PhD, Assistant Professor at Faculty of Physical Therapy, Cairo University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Shaimaa Mohamed Ahmed Elsayeh, Lecturer of physical therapy, Cairo University
    ClinicalTrials.gov Identifier:
    NCT05849701
    Other Study ID Numbers:
    • P.T/INTG/3/2023/45
    First Posted:
    May 9, 2023
    Last Update Posted:
    May 9, 2023
    Last Verified:
    May 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Shaimaa Mohamed Ahmed Elsayeh, Lecturer of physical therapy, Cairo University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 9, 2023